Top

American Journal of Clinical Dermatology

Published in:

01-12-2012 | Original Research Article

Alterations in Serum Lipid Profile Patterns in Oral Lichen Planus

A Cross-Sectional Study

Authors: Dr Pia López-Jornet, Fabio Camacho-Alonso, M. Angeles Rodríguez-Martínes

Published in: American Journal of Clinical Dermatology | Issue 6/2012

Abstract

Background: Oral lichen planus (OLP) is a chronic inflammatory disorder. Recently, a case-control study found that lichen planus was associated with dyslipidemia in a large series of patients. However, no data were presented about lipid values in patients and controls.

Objectives: The aim of this study was to investigate the hypothetical association between OLP and dyslipidemia.

Materials and Methods: The study included a total of 400 patients (200 with OLP and 200 controls with other oral diseases) and investigated the prevalence of dyslipidemia. The variables analyzed were age, sex, tobacco and alcohol consumption, clinical form of OLP and lipid profiles.

Results: A 54% prevalence of dyslipidemia was found (58% among the OLP group and 50% in the control group). Statistically significant differences in high-density lipoprotein were found between OLP patients and the control group (p =0.003). A logistic regression model for presence/absence of cardiovascular risk (Castelli’s atherogenic index of ≥5.1 for men and ≥4.5 for women) found statistically significant differences for sex and tobacco consumption.

Conclusions: The study found a higher atherogenic index amongst OLP patients.

Lodi G, Scully Carrozzo M, et al. Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100:40–51PubMedCrossRef

Jin Lin X, Ming-Wen F, Shuo-Zhi W, et al. A clinical study of 674 patients with oral lichen planus in China. J Oral Pathol Med 2005; 34: 467–72CrossRef

Bermejo-Fenoll A, Sánchez-Siles M, López-Jornet P, et al. A retrospective clinicopathological study of 550 patients with oral lichen planus in southeastern Spain. J Oral Pathol Med 2010; 39: 491–6PubMedCrossRef

Bermejo-Fenoll A, Sánchez-Siles M, López-Jornet P, et al. Premalignant nature of oral lichen planus: a retrospective study of 550 oral lichen planus patients from south-eastern Spain. Oral Oncol 2009; 45: e54–6PubMedCrossRef

Roopashree MR, Gondhalekar RV, Shashikanth MC, et al. Pathogenesis of oral lichen planus: a review. J Oral Pathol Med 2010; 39: 729–34PubMedCrossRef

van der Meij EH, van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 2003; 32: 507–12PubMedCrossRef

van der Waal I. Oral lichen planus and oral lichenoid lesions; a critical appraisal with emphasis on the diagnostic aspects. Med Oral Patol Oral Cir Bucal 2009; 14: E310–4PubMed

Scully C, Carrozzo M. Oral mucosal disease: lichen planus. Br J Oral Max-illofac Surg 2008; 46: 15–21CrossRef

Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol 2002; 46: 207–14PubMedCrossRef

10.

Powell SM, Ellis JP, Ryan TJ, et al. Glucose tolerance in lichen planus. Br J Dermatol 1974; 91: 23–5CrossRef

11.

Blanco A, Gándara JM, Rodríguez A, et al. Alteraciones bioquímicas y su correlación clínica con el liquen plano oral. Medicina Oral 2000; 5: 14–25

12.

Grinspan D, Diaz J, Villapol LO, et al. Lichen ruber planus of the buccal mucosa: its association with diabetes. Bull Soc Fr Dermatol Syphiligr 1966; 73: 898–9PubMed

13.

Mignogna MD, Fedele S, Lo Russo L, et al. Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence? Oral Oncol 2004; 40(2): 120–30PubMedCrossRef

14.

Liu Y, Messadi DV, Wu H, et al. Oral lichen planus is a unique disease model for studying chronic inflammation and oral cancer. Med Hypotheses 2010; 75: 492–4PubMedCrossRef

15.

Sezer E, Ozugurlu F, Ozyurt H, et al. Lipid peroxidation and antioxidant status in lichen planus. Clin Exp Dermatol 2007; 32: 430–4PubMedCrossRef

16.

Pezelj-Ribaric S, Prso IB, Abram M, et al. Salivary levels of tumor necrosis factor-alpha in oral lichen planus. Mediators Inflamm 2004; 13: 131–3PubMedCrossRef

17.

Dreiher J, Shapiro J, Cohen AD. Lichen planus and dyslipidaemia: a case-control study. Br J Dermatol 2009; 161: 626–9PubMedCrossRef

18.

Arias-Santiago S, Buendía-Eisman A, Aneiros-Fernández J, et al. Cardiovascular risk factors in patients with lichen planus. Am J Med 2011; 124: 543–8PubMedCrossRef

19.

Arias-Santiago S, Buendía-Eisman A, Aneiros-Fernández J, et al. Lipid levels in patients with lichen planus: a case-control study. J Eur Acad Dermatol Venereol 2011;25: 1398–40PubMedCrossRef

20.

Fedele S, Sabbah W, Donos N, et al. Common oral mucosal diseases, systemic inflammation and cardiovascular diseases in a large cross-sectional US survey. Am Heart J 2011; 161: 344–50PubMedCrossRef

21.

WHO Collaborating Centre for Oral Precancerous Lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978; 46: 518–39CrossRef

22.

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NECP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–97CrossRef

23.

Simark-Mattsson C, Bergenholtz G, Jontell M, et al. Distribution of inter- leukin-2, -4,-10, tumor necrosis factor-alpha and transforming growth factor-beta mRNAs in oral lichen planus. Arch Oral Biol 1999; 44: 499–507PubMedCrossRef

24.

Bagan JV, Donat FJ, Penarrocha M, et al. Oral lichen planus and diabetes mellitus. A clinico-pathological study. Bull Group Int Rech Sci Stomatol Odontol 1993; 36: 3–6PubMed

25.

Romero MA, Seoane J, Varela-Centelles P, et al. Prevalence of diabetes mellitus amongst oral lichen planus patients: clinical and pathological characteristics. Med Oral 2002; 7: 121–9PubMed

26.

Borghelli RF, Pettinari IL, Chuchurru JA, et al. Oral lichen planus in patients with diabetes. An epidemiologic study. Oral Surg Oral Med Oral Pathol 1993; 75: 498–500PubMedCrossRef

27.

Schwingshackl L, Strasser B, Hoffmann G. Effects of monounsaturated fatty acids on cardiovascular risk factors: a systematic review and meta-analysis. Ann Nutr Metab 2011; 59: 176–86PubMedCrossRef

Title: Alterations in Serum Lipid Profile Patterns in Oral Lichen Planus
A Cross-Sectional Study
Authors: Dr Pia López-Jornet
Fabio Camacho-Alonso
M. Angeles Rodríguez-Martínes
Publication date: 01-12-2012
Publisher: Springer International Publishing
Published in: American Journal of Clinical Dermatology / Issue 6/2012
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI: https://doi.org/10.2165/11633600-000000000-00000

At a glance: The STEP trials

Springer Medicine

Alterations in Serum Lipid Profile Patterns in Oral Lichen Planus

A Cross-Sectional Study

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2012

A Review of Pediatric Vasculitis with a Focus on Juvenile Polyarteritis Nodosa

Newer Approaches to the Treatment of Acne Vulgaris

Lichen Planus-Like Drug Eruptions Due to β-Blockers

Comparative Efficacy of Biologics in Psoriasis

Erratum to Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis

Nail Psoriasis